Cell Banking Outsourcing Market Scope
Cell banking is the process of reproducing and conserving cells for future use. These cell samples can be stored indefinitely for use in research and surgical tissue regeneration. Cryoprotection agents such as DMSO (10%) solution are used to freeze cells in cryovials at -196 degrees Celsius. The most common application of cell banking is in stem cell research and therapy. Cell banks can be divided into two types: master cell banks and operational cell banks. Expanding master cell banks create working cell banks. Master cell banks have pure cells from which cells are replicated, whereas working cell banks have thawed cells that are replicated in cell culture.
The Cell Banking Outsourcing market study is segmented by Type (Master Cell Banking, Working Cell Banking and Viral Cell Banking) and major geographies with country level break-up.
The cell banking outsourcing market is characterized by the presence of several global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies. The growing need for mobile banking outsourcing is propelling the market forward. In this highly competitive industry, players compete and collaborate to gain a considerable market share. In February 2021, Catalent (US) and Trizell GmbH (Germany) signed an agreement to facilitate the manufacturing of Trizell's Phase 1 cell therapy for the treatment of micro-and macroangiopathies. The top firms have developed strategic alliances and joint ventures to maintain their market positions.
BioReliance (United States), Global Stem Inc (United States), BSL Disservice (United States), Clean cells (France), Charles River Laboratories Lonza (United States), Toxikon Corporation (United States), Cryobanks International (India), Wuxi Apptec (China), Reliance Life Sciences (India) and BioOutsource (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are CordLife (Singapore), PX’Therapeutics SA (France) and SGS Life Sciences (India).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Cell Banking Outsourcing market by Type, Application and Region.
On the basis of geography, the market of Cell Banking Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In Feb 2021, CiRC Biosciences, a cell therapy firm founded by Paragon Biosciences in the United States, is researching remedies for diseases with a high unmet need, with an initial focus on eye disorders. and In April 2020, Hope Biosciences (US), a clinical-stage startup focused on cell-based treatments, has acquired FDA permission for Phase II clinical research testing the efficacy and safety of its mesenchymal stem cells in providing immunological support against COVID-19.
- Rapid Advancement in the Banking Sector
- Increasing Awareness Regarding Stem Cell Therapies
- Increasing Adoption of Collaboration and Acquisition Strategies by Market Key Players
- Increasing Stem Cell Research and Development Endeavours in the Production of Novel Therapeutic Options for Rare Diseases
- Development of Cell Banks in Developing Countries
- Increasing Funding and Government Rules
- Innovating New Products and Services in Developing Countries
- High Cost Associated With Storing Cells in Cell Banks
- High Capital Investment
- Strict Government Rules and Increased competition in the market
Key Target AudienceIndustry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors
Frequently Asked Questions (FAQ):
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Cell Banking Outsourcing Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.